China Sxt Pharmaceuticals Inc
(SXTC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 09-2022 | 03-2022 | 09-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,935 | -1,495 | -5,736 | -3,092 | -2,748 |
| Depreciation Amortization | 250 | 110 | 320 | 186 | 345 |
| Other Working Capital | 1,416 | 247 | 1,903 | 2,308 | -1,606 |
| Other Operating Activity | 4,188 | 589 | 3,781 | 286 | 2,692 |
| Operating Cash Flow | $-81 | $-549 | $268 | $-312 | $-1,317 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71 | -20 | -63 | -21 | -93 |
| Other Investing Activity | 58 | 59 | 16 | -9,281 | -5,713 |
| Investing Cash Flow | $-12 | $39 | $-47 | $-9,302 | $-5,806 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,942 | -11,069 | 1,595 | -3,909 | 12,409 |
| Financing Cash Flow | $2,942 | $-11,069 | $1,595 | $-3,909 | $12,409 |
| Exchange Rate Effect | -1,050 | -1,009 | 394 | 197 | 785 |
| Beginning Cash Position | 15,570 | 15,570 | 13,359 | 13,359 | 7,287 |
| End Cash Position | 17,368 | 2,981 | 15,570 | 31 | 13,359 |
| Net Cash Flow | $1,799 | $-12,589 | $2,211 | $-13,328 | $6,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81 | -549 | 268 | -312 | -1,317 |
| Free Cash Flow | -81 | -549 | 268 | -312 | -1,317 |